{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:29:58Z","timestamp":1785767398781,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study investigated the effect of poor balance and sarcopenia on vertebral spinal osteoporotic fracture (VOPF) in female rheumatoid arthritic (RA) patients. A total of 195 female RA and 126 normal subjects were enrolled, and the correlations between sarcopenia, poor balance and VOPF were analyzed. Furthermore, we explored the relationships between sarcopenia or poor balance with disease related indexes of female RA. Binary logistic regression analyses were performed to identify potential risk factors for VOPF in female RA. We found that female RA had an increased risk of sarcopenia, poor balance (Berg balance scale, BBS\u2009\u2264\u200940) and VOPF than controls (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). Female RA with VOPF were more likely to have poor balance and sarcopenia than those without VOPF (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001\u20130.05). Meanwhile, female RA with sarcopenia and poor balance often had higher disease activity, more serious joint damage and worse joint function (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) compared with those without sarcopenia and poor balance. Binary logistic regression analysis (LR backwald) revealed that age (OR\u2009=\u20091.112, 95% CI 1.065\u20131.160, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), OP (OR\u2009=\u200910.137, 95% CI 4.224\u201324.330, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) and GCs usage (OR\u2009=\u20093.532, 95% CI 1.427\u20138.741, <jats:italic>P<\/jats:italic>\u2009=\u20090.006) were risk factors, while SMI (OR\u2009=\u20090.386, 95% CI 0.243\u20130.614, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) and BBS (OR\u2009=\u20090.952, 95% CI 0.929\u20130.976, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) were protective factors for VOPF in female RA. Hence, sarcopenia and poor balance are associated with a higher risk for VOPF and are closely related to disease activity and joint structure damage of female RA.<\/jats:p>","DOI":"10.1038\/s41598-022-13339-2","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T17:04:00Z","timestamp":1654707840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of sarcopenia and poor balance on vertebral spinal osteoporotic fracture in female rheumatoid arthritis"],"prefix":"10.1038","volume":"12","author":[{"given":"Mei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexiang","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"13339_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11926-019-0836-7","volume":"21","author":"G Adami","year":"2019","unstructured":"Adami, G. & Saag, K. G. Osteoporosis pathophysiology, epidemiology, and screening in rheumatoid arthritis. Curr. Rheumatol. Rep. 21, 34 (2019).","journal-title":"Curr. Rheumatol. Rep."},{"key":"13339_CR2","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1016\/S2665-9913(19)30136-5","volume":"2","author":"C Roux","year":"2020","unstructured":"Roux, C. & Briot, K. The crisis of inadequate treatment in osteoporosis. Lancet Rheumatol. 2, e110\u2013e119 (2020).","journal-title":"Lancet Rheumatol."},{"key":"13339_CR3","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1080\/14656566.2020.1787381","volume":"21","author":"HG Raterman","year":"2020","unstructured":"Raterman, H. G., Bultink, I. E. & Lems, W. F. Osteoporosis in patients with rheumatoid arthritis: An update in epidemiology, pathogenesis, and fracture prevention. Expert Opin. Pharmacother. 21, 1725\u20131737 (2020).","journal-title":"Expert Opin. Pharmacother."},{"key":"13339_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","volume":"12","author":"J Compston","year":"2017","unstructured":"Compston, J. et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 12, 43 (2017).","journal-title":"Arch Osteoporos."},{"key":"13339_CR5","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/rheumatology\/keu162","volume":"53","author":"B Hauser","year":"2014","unstructured":"Hauser, B., Riches, P. L., Wilson, J. F., Horne, A. E. & Ralston, S. H. Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology 53, 1759\u20131766 (2014).","journal-title":"Rheumatology"},{"key":"13339_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","volume":"43","author":"G Haugeberg","year":"2000","unstructured":"Haugeberg, G., Uhlig, T., Falch, J. A., Halse, J. I. & Kvien, T. K. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum. 43, 522\u2013530 (2000).","journal-title":"Arthritis Rheum."},{"key":"13339_CR7","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00296-016-3453-z","volume":"36","author":"D Kim","year":"2016","unstructured":"Kim, D. et al. Incidence and risk factors of fractures in patients with rheumatoid arthritis: An Asian prospective cohort study. Rheumatol. Int. 36, 1205\u20131214 (2016).","journal-title":"Rheumatol. Int."},{"key":"13339_CR8","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00198-018-4473-1","volume":"29","author":"S Jin","year":"2018","unstructured":"Jin, S. et al. Incidence of fractures among patients with rheumatoid arthritis: A systematic review and meta-analysis. Osteoporos. Int. 29, 1263\u20131275 (2018).","journal-title":"Osteoporos. Int."},{"key":"13339_CR9","doi-asserted-by":"publisher","first-page":"e6983","DOI":"10.1097\/MD.0000000000006983","volume":"96","author":"AL Xue","year":"2017","unstructured":"Xue, A. L. et al. Bone fracture risk in patients with rheumatoid arthritis: A meta-analysis. Medicine (Baltimore) 96, e6983 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"13339_CR10","doi-asserted-by":"publisher","first-page":"e5262","DOI":"10.1097\/MD.0000000000005262","volume":"95","author":"B Chen","year":"2016","unstructured":"Chen, B., Cheng, G., Wang, H. & Feng, Y. Increased risk of vertebral fracture in patients with rheumatoid arthritis: A meta-analysis. Medicine (Baltimore) 95, e5262 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"13339_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12016-018-8672-5","volume":"56","author":"EG Favalli","year":"2019","unstructured":"Favalli, E. G. et al. Sex and management of rheumatoid arthritis. Clin. Rev. Allergy Immunol. 56, 333\u2013345 (2019).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"13339_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 48, 16\u201331 (2019).","journal-title":"Age Ageing."},{"key":"13339_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/jcsm.12189","volume":"8","author":"A Tournadre","year":"2017","unstructured":"Tournadre, A. et al. Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis. J. Cachexia Sarcopenia Muscle. 8, 639\u2013646 (2017).","journal-title":"J. Cachexia Sarcopenia Muscle."},{"key":"13339_CR14","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1007\/s00198-017-4151-8","volume":"28","author":"HP Hirschfeld","year":"2017","unstructured":"Hirschfeld, H. P., Kinsella, R. & Duque, G. Osteosarcopenia: Where bone, muscle, and fat collide. Osteoporos. Int. 28, 2781\u20132790 (2017).","journal-title":"Osteoporos. Int."},{"key":"13339_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/art.1780350502","volume":"35","author":"MC Hochberg","year":"1992","unstructured":"Hochberg, M. C. et al. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum. 35, 498\u2013502 (1992).","journal-title":"Arthritis Rheum."},{"key":"13339_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"LK Chen","year":"2014","unstructured":"Chen, L. K. et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. J. Am. Med. Dir. Assoc. 15, 95\u2013101 (2014).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"13339_CR17","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1080\/09638280400000245","volume":"26","author":"S Jansson","year":"2004","unstructured":"Jansson, S. & S\u00f6derlund, A. A new treatment programme to improve balance in elderly people-an evaluation of an individually tailored home-based exercise programme in five elderly women with a feeling of unsteadiness. Disabil. Rehabil. 26, 1434\u20131443 (2004).","journal-title":"Disabil. Rehabil."},{"key":"13339_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1519\/00139143-200831010-00006","volume":"31","author":"F Sahin","year":"2008","unstructured":"Sahin, F. et al. Reliability and validity of the Turkish version of the Berg Balance Scale. J. Geriatr. Phys. Ther. 31, 32\u201337 (2008).","journal-title":"J. Geriatr. Phys. Ther."},{"key":"13339_CR19","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1097\/BOT.0000000000000949","volume":"31","author":"S Rajasekaran","year":"2017","unstructured":"Rajasekaran, S. et al. Osteoporotic thoracolumbar fractures-how are they different? Classification and treatment algorithm. J. Orthop. Trauma. 31, S49\u2013S56 (2017).","journal-title":"J. Orthop. Trauma."},{"key":"13339_CR20","first-page":"261","volume":"27","author":"D van der Heijde","year":"2000","unstructured":"van der Heijde, D. How to read radiographs according to the Sharp\/van der Heijde method. J. Rheumatol. 27, 261\u2013263 (2000).","journal-title":"J. Rheumatol."},{"key":"13339_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00198-011-1584-3","volume":"23","author":"M Ghazi","year":"2012","unstructured":"Ghazi, M. et al. Prevalence of vertebral fractures in patients with rheumatiodarthritis: Revisiting the role of glucocorticiods. Osteoporosis. Int. 23, 581\u2013587 (2012).","journal-title":"Osteoporosis. Int."},{"key":"13339_CR22","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/annrheumdis-2012-202958","volume":"73","author":"A Kleyer","year":"2014","unstructured":"Kleyer, A. et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann. Rheum. Dis. 73, 854\u2013860 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"13339_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10067-019-04787-9","volume":"39","author":"JJ Tong","year":"2020","unstructured":"Tong, J. J. et al. Prevalence and risk factors associated with vertebral osteoporotic fractures in patients with rheumatoid arthritis. Clin. Rheumatol. 39, 357\u2013364 (2020).","journal-title":"Clin. Rheumatol."},{"key":"13339_CR24","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s40266-019-00714-4","volume":"36","author":"HG Raterman","year":"2019","unstructured":"Raterman, H. G. & Lems, W. F. Pharmacological management of osteoporosis in rheumatoid arthritis patients: A review of the literature and practical guide. Drugs Aging. 36, 1061\u20131072 (2019).","journal-title":"Drugs Aging."},{"key":"13339_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.110835","volume":"132","author":"MM de Freitas","year":"2020","unstructured":"de Freitas, M. M. et al. Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Exp. Gerontol. 132, 110835 (2020).","journal-title":"Exp. Gerontol."},{"key":"13339_CR26","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/ageing\/afu115","volume":"43","author":"AJ Cruz-Jentoft","year":"2014","unstructured":"Cruz-Jentoft, A. J. et al. Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 43, 748\u2013759 (2014).","journal-title":"Age Ageing."},{"key":"13339_CR27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/14397595.2018.1510565","volume":"29","author":"M Torii","year":"2019","unstructured":"Torii, M. et al. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis. Mod. Rheumatol. 29, 589\u2013595 (2019).","journal-title":"Mod. Rheumatol."},{"key":"13339_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5152\/eurjrheum.2015.0038","volume":"2","author":"SC Do\u011fan","year":"2015","unstructured":"Do\u011fan, S. C. et al. Sarcopenia in women with rheumatoid arthritis. Eur. J. Rheumatol. 2, 57\u201361 (2015).","journal-title":"Eur. J. Rheumatol."},{"key":"13339_CR29","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/ggi.13747","volume":"19","author":"T Mochizuki","year":"2019","unstructured":"Mochizuki, T., Yano, K., Ikari, K. & Okazaki, K. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study. Geriatr. Gerontol. Int. 19, 907\u2013912 (2019).","journal-title":"Geriatr. Gerontol. Int."},{"key":"13339_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00296-017-3665-x","volume":"37","author":"A Ngeuleu","year":"2017","unstructured":"Ngeuleu, A. et al. Sarcopenia in rheumatoid arthritis: Prevalence, influence of disease activity and associated factors. Rheumatol. Int. 37, 1015\u20131020 (2017).","journal-title":"Rheumatol. Int."},{"key":"13339_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semarthrit.2020.10.002","volume":"51","author":"TH Li","year":"2021","unstructured":"Li, T. H. et al. The prevalence and risk factors of sarcopenia in rheumatoid arthritis patients: A systematic review and meta-regression analysis. Semin. Arthritis. Rheum. 51, 236\u2013245 (2021).","journal-title":"Semin. Arthritis. Rheum."},{"key":"13339_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.archger.2018.04.013","volume":"77","author":"D Urrunaga-Pastor","year":"2018","unstructured":"Urrunaga-Pastor, D. et al. Factors associated with poor balance ability in older adults of nine high-altitude communities. Arch. Gerontol. Geriatr. 77, 108\u2013114 (2018).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"13339_CR33","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1007\/s10067-021-05703-w","volume":"40","author":"YF Chen","year":"2021","unstructured":"Chen, Y. F. et al. Synergistic effect of sarcopenia and poor balance on osteoporotic vertebral fracture in Chinese patients with rheumatoid arthritis. Clin. Rheumatol. 40, 3627\u20133637 (2021).","journal-title":"Clin. Rheumatol."},{"key":"13339_CR34","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00198-009-1150-4","volume":"21","author":"M Hayashibara","year":"2010","unstructured":"Hayashibara, M. et al. Incidence and risk factors of falling in ambulatory patients with rheumatoid arthritis: A prospective 1-year study. Osteoporos. Int. 21, 1825\u20131833 (2010).","journal-title":"Osteoporos. Int."},{"key":"13339_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13075-018-1566-3","volume":"20","author":"G Orsolini","year":"2018","unstructured":"Orsolini, G. et al. Anti-CCP antibodies and bone. Arthritis Res. Ther. 20, 63 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"13339_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00223-017-0253-8","volume":"101","author":"G Orsolini","year":"2017","unstructured":"Orsolini, G. et al. Titer-dependent effect of anti-citrullinated protein antibodies on systemic bone mass in rheumatoid arthritis patients. Calcif. Tissue Int. 101, 17\u201323 (2017).","journal-title":"Calcif. Tissue Int."},{"key":"13339_CR37","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0049-2019","volume":"28","author":"E Benz","year":"2019","unstructured":"Benz, E. et al. Sarcopenia in COPD: A systematic review and meta-analysis. Eur. Respir. Rev. 28, 190049 (2019).","journal-title":"Eur. Respir. Rev."},{"key":"13339_CR38","doi-asserted-by":"publisher","first-page":"M326","DOI":"10.1093\/gerona\/57.5.M326","volume":"57","author":"M Visser","year":"2002","unstructured":"Visser, M. et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J. Gerontol. A Biol. Sci. Med. Sci. 57, M326-332 (2002).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"13339_CR39","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3389\/fphys.2017.01045","volume":"8","author":"S Dalle","year":"2017","unstructured":"Dalle, S., Rossmeislova, L. & Koppo, K. The Role of inflammation in age-related sarcopenia. Front. Physiol. 8, 1045 (2017).","journal-title":"Front. Physiol."},{"key":"13339_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fphys.2016.00361","volume":"7","author":"SS Rudrappa","year":"2016","unstructured":"Rudrappa, S. S. et al. Human skeletal muscle disuse atrophy: Effects on muscle protein synthesis, breakdown, and insulin resistance\u2014A qualitative review. Front. Physiol. 7, 361 (2016).","journal-title":"Front. Physiol."},{"key":"13339_CR41","doi-asserted-by":"publisher","first-page":"926","DOI":"10.14740\/jocmr2361w","volume":"7","author":"H Yanai","year":"2015","unstructured":"Yanai, H. Nutrition for sarcopenia. J. Clin. Med. Res. 7, 926\u2013931 (2015).","journal-title":"J. Clin. Med. Res."},{"key":"13339_CR42","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1136\/ard.2004.028209","volume":"63","author":"LH Calabrese","year":"2004","unstructured":"Calabrese, L. H., Zein, N. & Vassilopoulos, D. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: Hepatitis C, hepatitis B, and HIV infection. Ann. Rheum. Dis. 63, ii18\u2013ii24 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"13339_CR43","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1093\/rheumatology\/kem291","volume":"46","author":"GS Metsios","year":"2007","unstructured":"Metsios, G. S. et al. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford) 46, 1824\u20131827 (2007).","journal-title":"Rheumatology (Oxford)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13339-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13339-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13339-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:55:14Z","timestamp":1669348514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13339-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13339"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13339-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9477"}}